![Ronald K. Poropatich](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ronald K. Poropatich
Directeur/Membre du Conseil chez Noveome Biotherapeutics, Inc.
Profil
Ronald K.
Poropatich is currently the Director at Noveome Biotherapeutics, Inc. He received his undergraduate degree from Drexel University in 1985.
Postes actifs de Ronald K. Poropatich
Sociétés | Poste | Début |
---|---|---|
Noveome Biotherapeutics, Inc.
![]() Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | Directeur/Membre du Conseil | 25/01/2021 |
Formation de Ronald K. Poropatich
Drexel University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Noveome Biotherapeutics, Inc.
![]() Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | Health Technology |